Cargando…

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease

Accumulation of β-amyloid (Aβ) in the brain is associated with memory decline in healthy individuals as a prelude to Alzheimer's disease (AD). Genetic factors may moderate this decline. We examined the role of apolipoprotein E (ɛ4 carrier[ɛ4(+)], ɛ4 non-carrier[ɛ4(−)]) and brain-derived neurotr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Y Y, Villemagne, V L, Laws, S M, Pietrzak, R H, Snyder, P J, Ames, D, Ellis, K A, Harrington, K, Rembach, A, Martins, R N, Rowe, C C, Masters, C L, Maruff, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759101/ https://www.ncbi.nlm.nih.gov/pubmed/25288138 http://dx.doi.org/10.1038/mp.2014.123

Ejemplares similares

Amyloid-Related Memory Decline in Preclinical Alzheimer’s Disease Is Dependent on APOE ε4 and Is Detectable over 18-Months
por: Thai, Christine, et al.
Publicado: (2015)

Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study
por: Lim, Yen Ying, et al.
Publicado: (2014)

Amyloid β–associated cognitive decline in the absence of clinical disease progression and systemic illness
por: Harrington, Karra D., et al.
Publicado: (2017)

SPON1 Is Associated with Amyloid-β and APOE ε4-Related Cognitive Decline in Cognitively Normal Adults
por: Fernandez, Shane, et al.
Publicado: (2021)

KIBRA is associated with accelerated cognitive decline and hippocampal atrophy in APOE ε4-positive cognitively normal adults with high Aβ-amyloid burden
por: Porter, Tenielle, et al.
Publicado: (2018)

COMT val158met is not associated with Aβ-amyloid and APOE ε4 related cognitive decline in cognitively normal older adults
por: Porter, Tenielle, et al.
Publicado: (2019)

Sensitivity of composite scores to amyloid burden in preclinical Alzheimer's disease: Introducing the Z-scores of Attention, Verbal fluency, and Episodic memory for Nondemented older adults composite score
por: Lim, Yen Ying, et al.
Publicado: (2015)

A Polygenic Risk Score Derived From Episodic Memory Weighted Genetic Variants Is Associated With Cognitive Decline in Preclinical Alzheimer’s Disease
por: Porter, Tenielle, et al.
Publicado: (2018)

Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis
por: Baker, Jenalle E., et al.
Publicado: (2016)

Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
por: Gardener, Samantha L., et al.
Publicado: (2021)

Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance
por: Dang, Christa, et al.
Publicado: (2019)

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study
por: Villemagne, Victor L., et al.
Publicado: (2017)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain Aβ-amyloid burden
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Validation of a priori candidate Alzheimer’s disease SNPs with brain amyloid-beta deposition
por: Vacher, Michael, et al.
Publicado: (2019)

Determining clinically meaningful decline in preclinical Alzheimer disease
por: Insel, Philip S., et al.
Publicado: (2019)

Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
por: van der Kall, Laura M., et al.
Publicado: (2021)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
por: Ashton, Nicholas J., et al.
Publicado: (2019)

Mediterranean diet adherence and rate of cerebral Aβ-amyloid accumulation: Data from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
por: Rainey-Smith, Stephanie R., et al.
Publicado: (2018)

Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging
por: Gupta, Veer Bala, et al.
Publicado: (2015)

MR-Less Surface-Based Amyloid Assessment Based on (11)C PiB PET
por: Zhou, Luping, et al.
Publicado: (2014)

Baseline White Matter Is Associated With Physical Fitness Change in Preclinical Alzheimer’s Disease
por: Venkatraman, Vijay K., et al.
Publicado: (2020)

Assessing risk for preclinical β-amyloid pathology with APOE, cognitive, and demographic information
por: Insel, Philip S., et al.
Publicado: (2016)

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
por: Pascoal, T A, et al.
Publicado: (2017)

Exploring discordant low amyloid beta and high neocortical tau positron emission tomography cases
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Mesial temporal tau in amyloid-β-negative cognitively normal older persons
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Visually Identified Tau (18)F-MK6240 PET Patterns in Symptomatic Alzheimer’s Disease
por: Krishnadas, Natasha, et al.
Publicado: (2022)

Relationship between amyloid and tau levels and its impact on tau spreading
por: Doré, Vincent, et al.
Publicado: (2021)

Amyloid and tau signatures of brain metabolic decline in preclinical Alzheimer’s disease
por: Pascoal, Tharick A., et al.
Publicado: (2018)

Functional MRI and ApoE4 genotype for predicting cognitive decline in amyloid-positive individuals
por: Zhu, Jun-Ding, et al.
Publicado: (2022)

Plasma transferrin and hemopexin are associated with altered Aβ uptake and cognitive decline in Alzheimer’s disease pathology
por: Ashraf, Azhaar, et al.
Publicado: (2020)

A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
por: Pedrini, Steve, et al.
Publicado: (2017)

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume
por: Milicic, Lidija, et al.
Publicado: (2022)

Brain ApoA-I, ApoJ and ApoE Immunodetection in Cerebral Amyloid Angiopathy
por: Camacho, Jessica, et al.
Publicado: (2019)

Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
por: Buckley, Rachel F., et al.
Publicado: (2019)

Association of naturally occurring antibodies to β-amyloid with cognitive decline and cerebral amyloidosis in Alzheimer’s disease
por: Liu, Yu-Hui, et al.
Publicado: (2021)

No Influence of Age-Related Hearing Loss on Brain Amyloid-β
por: Sarant, Julia Z., et al.
Publicado: (2022)

(18)F-Florbetaben PET beta-amyloid binding expressed in Centiloids
por: Rowe, Christopher C., et al.
Publicado: (2017)

Cognitive Decline in Preclinical Alzheimer’s Disease: Amyloid-Beta versus Tauopathy
por: Huber, Colin M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_je42lr86h6krb51kc2f956kb3u